Zydus Cadila gets green light by USFDA for Isosorbide Dinitrate tablets, Desonide Cream

Drug firm
Zydus Cadila on Thursday said it has received approval from the US health
regulator to market Isosorbide Dinitrate tablets used to prevent attacks of
chest pain.

The drug
firm has also received final approval from US health regulator for Desonide
Cream, used to treat a variety of skin conditions like eczema, dermatitis,
allergies and rash, the company said.

The drug is
used to prevent attacks of chest pain. lt expands blood vessels, making it
easier for blood to flow through them and easier for the heart to pump.

It will be
manufactured at the Group’s formulations manufacturing facility at Baddi,
Himachal Pradesh.

The group
also received the final approval for Desonide Cream (US RLD – Desonide Cream),
0.05%, the BSE filing said.